1
|
Mitchell RM, Byrne MF and Baillie J:
Pancreatitis. Lancet. 361:1447–1455. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang J, Niu J and Yang J: Interleukin-6,
interleukin-8 and interleukin-10 in estimating the severity of
acute pancreatitis: an updated meta-analysis.
Hepatogastroenterology. 61:215–220. 2014.PubMed/NCBI
|
3
|
Wang XY, Tang QQ, Zhang JL, Fang MY and Li
YX: Effect of SB203580 on pathologic change of pancreatic tissue
and expression of TNF-α and IL-1β in rats with severe acute
pancreatitis. Eur Rev Med Pharmacol Sci. 18:338–343.
2014.PubMed/NCBI
|
4
|
Singh VK, Wu BU, Bollen TL, Repas K,
Maurer R, Mortele KJ and Banks PA: Early systemic inflammatory
response syndrome is associated with severe acute pancreatitis.
Clin Gastroenterol Hepatol. 7:1247–1251. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sathyanarayan G, Garg PK, Prasad H and
Tandon RK: Elevated level of interleukin-6 predicts organ failure
and severe disease in patients with acute pancreatitis. J
Gastroenterol Hepatol. 22:550–554. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Liu Y, Wang L, Cai Z, Zhao P, Peng C, Zhao
L and Wan C: The decrease of peripheral blood CD4+ T
cells indicates abdominal compartment syndrome in severe acute
pancreatitis. PLoS One. 10:e01357682015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Pezzilli R, Billi P, Gullo L, Beltrandi E,
Maldini M, Mancini R, Incorvaia L and Miglioli M: Behavior of serum
soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the
early phases of acute pancreatitis. Digestion. 55:268–273. 1994.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Pezzilli R, Billi P, Beltrandi E, Maldini
M, Mancini R, Labate AM Morselli and Miglioli M: Circulating
lymphocyte subsets in human acute pancreatitis. Pancreas.
11:95–100. 1995. View Article : Google Scholar : PubMed/NCBI
|
9
|
Uehara S, Gothoh K, Handa H, Tomita H and
Tomita Y: Immune function in patients with acute pancreatitis. J
Gastroenterol Hepatol. 18:363–370. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yang Z, Zhang Y, Dong L, Yang C, Gou S,
Yin T, Wu H and Wang C: The reduction of peripheral blood
CD4+ T cell indicates persistent organ failure in acute
pancreatitis. PLoS One. 10:e01255292015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lipinski M, Rydzewska-Rosolowska A,
Rydzewski A and Rydzewska G: Fluid resuscitation in acute
pancreatitis: normal saline or lactated Ringer's solution? World J
Gastroenterol. 21:9367–9372. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
de-Madaria E, Soler-Sala G, Sánchez-Payá
J, Lopez-Font I, Martínez J, Gómez-Escolar L, Sempere L,
Sánchez-Fortún C and Pérez-Mateo M: Influence of fluid therapy on
the prognosis of acute pancreatitis: a prospective cohort study. Am
J Gastroenterol. 106:1843–1850. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Mao EQ, Tang YQ, Fei J, Qin S, Wu J, Li L,
Min D and Zhang SD: Fluid therapy for severe acute pancreatitis in
acute response stage. Chin Med J (Engl). 122:169–173.
2009.PubMed/NCBI
|
14
|
Freitag M, Standl TG, Kleinhans H,
Gottschalk A, Mann O, Rempf C, Bachmann K, Gocht A, Petri S,
Izbicki JR, et al: Improvement of impaired microcirculation and
tissue oxygenation by hemodilution with hydroxyethyl starch plus
cell-free hemoglobin in acute porcine pancreatitis. Pancreatology.
6:232–239. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Du XJ, Hu WM, Xia Q, Huang ZW, Chen GY,
Jin XD, Xue P, Lu HM, Ke NW, Zhang ZD, et al: Hydroxyethyl starch
resuscitation reduces the risk of intra-abdominal hypertension in
severe acute pancreatitis. Pancreas. 40:1220–1225. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yang ZY, Wang CY, Jiang HC, Sun B, Zhang
ZD, Hu WM, Ou JR and Hou BH: Effects of early goal-directed fluid
therapy on intra-abdominal hypertension and multiple organ
dysfunction in patients with severe acute pancreatitis. Zhonghua
Wai Ke Za Zhi. 47:1450–1454. 2009.(In Chinese). PubMed/NCBI
|
17
|
Haase N, Perner A, Hennings LI, Siegemund
M, Lauridsen B, Wetterslev M and Wetterslev J: Hydroxyethyl starch
130/0.38-0.45 versus crystalloid or albumin in patients with
sepsis: systematic review with meta-analysis and trial sequential
analysis. BMJ. 346:f8392013. View
Article : Google Scholar : PubMed/NCBI
|
18
|
Zarychanski R, Abou-Setta AM, Turgeon AF,
Houston BL, McIntyre L, Marshall JC and Fergusson DA: Association
of hydroxyethyl starch administration with mortality and acute
kidney injury in critically ill patients requiring volume
resuscitation: a systematic review and meta-analysis. JAMA.
309:678–688. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Perner A, Haase N, Winkel P, Guttormsen
AB, Tenhunen J, Klemenzson G, Müller RG, Aneman A and Wetterslev J:
Long-term outcomes in patients with severe sepsis randomised to
resuscitation with hydroxyethyl starch 130/0.42 or Ringer's
acetate. Intensive Care Med. 40:927–934. 2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Perner A, Haase N, Guttormsen AB, Tenhunen
J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen
LM, et al: 6S Trial Group; Scandinavian Critical Care Trials Group:
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe
sepsis. N Engl J Med. 367:124–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Öztürk T, Onur E, Cerrahoğlu M, Çalgan M,
Nizamoglu F and Çivi M: Immune and inflammatory role of
hydroxyethyl starch 130/0.4 and fluid gelatin in patients
undergoing coronary surgery. Cytokine. 74:69–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Choi YS, Shim JK, Hong SW, Kim JC and Kwak
YL: Comparing the effects of 5% albumin and 6% hydroxyethyl starch
130/0.4 on coagulation and inflammatory response when used as
priming solutions for cardiopulmonary bypass. Minerva Anestesiol.
76:584–591. 2010.PubMed/NCBI
|
23
|
Balthazar EJ: Acute pancreatitis:
assessment of severity with clinical and CT evaluation. Radiology.
223:603–613. 2002. View Article : Google Scholar : PubMed/NCBI
|
24
|
Working Party of the British Society of
Gastroenterology; Association of Surgeons of Great Britain and
Ireland; Pancreatic Society of Great Britain and Ireland;
Association of Upper GI Surgeons of Great Britain and Ireland, . UK
guidelines for the management of acute pancreatitis. Gut. 54(Suppl
1): i1–i9. 2005.PubMed/NCBI
|
25
|
Group of Pancreas Surgery, Chinese Society
of Surgery, Chinese Medical Association, . The guideline of
diagnosis and treatment of severe acute pancreatitis. Zhonghua Wai
Ke Za Zhi. 45:727–729. 2007.(In Chinese). PubMed/NCBI
|
26
|
Uhl W, Warshaw A, Imrie C, Bassi C, McKay
CJ, Lankisch PG, Carter R, Di Magno E, Banks PA, Whitcomb DC, et
al: International Association of Pancreatology: IAP guidelines for
the surgical management of acute pancreatitis. Pancreatology.
2:565–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Malbrain ML, Cheatham ML, Kirkpatrick A,
Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C,
Ivatury R, et al: Results from the international conference of
experts on intra-abdominal hypertension and abdominal compartment
syndrome. I. Definitions. Intensive Care Med. 32:1722–1732. 2006.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Yang C, Yang Z, Chen X, Liu T, Gou S, Chen
C, Xiao J, Jin X, He Z, Dong L, et al: Inverted U-shaped
relationship between central venous pressure and intra-abdominal
pressure in the early phase of severe acute pancreatitis: a
retrospective study. PLoS One. 10:e01284932015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Makhija R and Kingsnorth AN: Cytokine
storm in acute pancreatitis. J Hepatobiliary Pancreat Surg.
9:401–410. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zyromski N and Murr MM: Evolving concepts
in the pathophysiology of acute pancreatitis. Surgery. 133:235–237.
2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Fink GW and Norman JG: Specific changes in
the pancreatic expression of the interleukin 1 family of genes
during experimental acute pancreatitis. Cytokine. 9:1023–1027.
1997. View Article : Google Scholar : PubMed/NCBI
|
32
|
Park J, Chang JH, Park SH, Lee HJ, Lim YS,
Kim TH, Kim CW and Han SW: Interleukin-6 is associated with
obesity, central fat distribution, and disease severity in patients
with acute pancreatitis. Pancreatology. 15:59–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Chen CC, Wang SS, Lee FY, Chang FY and Lee
SD: Proinflammatory cytokines in early assessment of the prognosis
of acute pancreatitis. Am J Gastroenterol. 94:213–218. 1999.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Exley AR, Leese T, Holliday MP, Swann RA
and Cohen J: Endotoxaemia and serum tumour necrosis factor as
prognostic markers in severe acute pancreatitis. Gut. 33:1126–1128.
1992. View Article : Google Scholar : PubMed/NCBI
|
35
|
Bunn F and Trivedi D: Colloid solutions
for fluid resuscitation. Cochrane Database Syst Rev.
7:CD0013192012.PubMed/NCBI
|
36
|
Zhao G, Zhang JG, Wu HS, Tao J, Qin Q,
Deng SC, Liu Y, Liu L, Wang B, Tian K, et al: Effects of different
resuscitation fluid on severe acute pancreatitis. World J
Gastroenterol. 19:2044–2052. 2013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Feng X, Yan W, Liu X, Duan M, Zhang X and
Xu J: Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary
leakage and cytokines production and NF-kappaB activation in
CLP-induced sepsis in rats. J Surg Res. 135:129–136. 2006.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Schäper J, Ahmed R, Schäfer T, Elster A,
Enigk F, Habazettl H, Mousa S, Schäfer M and Welte M: Volume
therapy with colloid solutions preserves intestinal microvascular
perfusion in endotoxaemia. Resuscitation. 76:120–128. 2008.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Lane JS, Todd KE, Gloor B, Chandler CF,
Kau AW, Ashley SW, Reber HA and McFadden DW: Platelet activating
factor antagonism reduces the systemic inflammatory response in a
murine model of acute pancreatitis. J Surg Res. 99:365–370. 2001.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Oiva J, Mustonen H, Kylänpää ML, Kyhälä L,
Kuuliala K, Siitonen S, Kemppainen E, Puolakkainen P and Repo H:
Acute pancreatitis with organ dysfunction associates with abnormal
blood lymphocyte signaling: controlled laboratory study. Crit Care.
14:R2072010. View
Article : Google Scholar : PubMed/NCBI
|
41
|
Nakayama S, Nishio A, Yamashina M, Okazaki
T, Sakaguchi Y, Yoshida K, Fukui T, Uchida K and Okazaki K:
Acquired immunity plays an important role in the development of
murine experimental pancreatitis induced by alcohol and
lipopolysaccharide. Pancreas. 43:28–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
42
|
Curley PJ, McMahon MJ, Lancaster F, Banks
RE, Barclay GR, Shefta J, Boylston AW and Whicher JT: Reduction in
circulating levels of CD4-positive lymphocytes in acute
pancreatitis: relationship to endotoxin, interleukin 6 and disease
severity. Br J Surg. 80:1312–1315. 1993. View Article : Google Scholar : PubMed/NCBI
|
43
|
Warndorf MG, Kurtzman JT, Bartel MJ, Cox
M, Mackenzie T, Robinson S, Burchard PR, Gordon SR and Gardner TB:
Early fluid resuscitation reduces morbidity among patients with
acute pancreatitis. Clin Gastroenterol Hepatol. 9:705–709. 2011.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Al-Bahrani AZ, Abid GH, Holt A, McCloy RF,
Benson J, Eddleston J and Ammori BJ: Clinical relevance of
intra-abdominal hypertension in patients with severe acute
pancreatitis. Pancreas. 36:39–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
45
|
Cunha AR and Lobo SM: What happens to the
fluid balance during and after recovering from septic shock? Rev
Bras Ter Intensiva. 27:10–17. 2015. View Article : Google Scholar : PubMed/NCBI
|
46
|
Lee J, de Louw E, Niemi M, Nelson R, Mark
RG, Celi LA, Mukamal KJ and Danziger J: Association between fluid
balance and survival in critically ill patients. J Intern Med.
277:468–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
47
|
Barmparas G, Liou D, Lee D, Fierro N,
Bloom M, Ley E, Salim A and Bukur M: Impact of positive fluid
balance on critically ill surgical patients: a prospective
observational study. J Crit Care. 29:936–941. 2014. View Article : Google Scholar : PubMed/NCBI
|
48
|
Boldt J: Hydroxyethyl starch:
pharmaceutical and clinical profile. Minerva Anestesiol.
65:305–309. 1999.PubMed/NCBI
|